Cardiff Oncology Inc. Made Big Gain
Tue, Dec 10, 2024 at 07:06 PM
Cardiff Oncology Inc. (CRDF:NASDAQ) jumped higher at $3.78, representing a gain of 54.9%. On Tue, Dec 10, 2024, CRDF:NASDAQ touched a New 2-Week High of $3.78. The stock appeared on our News Catalysts scanner on Tue, Dec 10, 2024 at 07:40 AM in the 'BIOTECH' category. From Tue, Nov 26, 2024, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Thu, Nov 07, 2024 at $4.38 with a volume of 1M+.
About Cardiff Oncology Inc. (CRDF:NASDAQ)
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...
Top 10 Gainers:
- Chimerix, Inc. (CMRX:NASDAQ), 219.08%
- uniQure N.V. (QURE:NASDAQ), 109.73%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 96.77%
- Roadzen Inc Ord Cl A (RDZN:NASDAQ), 57.58%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 54.92%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 47.48%
- SEALSQ Corp. (LAES:NASDAQ), 45.96%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 45.54%
- Rigetti Computing Inc. (RGTI:NASDAQ), 45.19%